ArticleParasites & vectors2025
Durability study of Veeralin
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIndia plans to eliminate malaria by 2030, targeting zero local cases by 2027. However, malaria remains prevalent in endemic regions. As a means of addressing this issue, insecticide-treated nets (ITNs) are crucial for prevention. In areas with pyrethroid-resistant vectors, studies indicate that ITNs containing pyrethroids and piperonyl butoxide (PBO) are more effective. However, their physical and chemical durability and bioefficacy in this setting require further evaluation. This study assessed the durability of two pyrethroid-PBO-treated nets and one pyrethroid-only-treated net to determine whether they met the World Health Organization (WHO)'s 3-year operational performance criteria for "long-lasting" classification.
methodsA total of 7570 ITNs-2664 Veeralin
resultsThe median functional survival period of the ITNs was estimated at 8 years (interquartile range [IQR] 7.00-9.00 years) for Veeralin
conclusionsIn the Indian geographic setting, Veeralin
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.